Castleman disease

Castleman disease (CD) is a benign lymphoproliferative disorder that may present as a localized or multicentric form (see these terms). The clinical manifestations are heterogeneous, ranging from asymptomatic discrete lymphadenopathy to recurrent episodes of diffuse lymphadenopathy with severe systemic symptoms.



Input patient's signs and symptoms


Narrow down the case reports



Total: 220 (papers)

  


(per page)
Matched Phenotype  Gene  Mutation  MeSH
Rank
(Similarity)
PMID
(PMCID)
21
(43.8%)
26490523
Multicentric Castleman Disease with Monoclonal Incomplete IgH Restriction: A Rare Coexistence.
Goyal G, Kendric K, Silberstein PT, Caponetti GC, Vivekanandan R.
J Clin Exp Hematop. 2015;55(2):103-8.
Anemia Fever Lymphadenopathy
IGH
Females Gene Rearrangement HIV Seropositivity Homo sapiens Immunoglobulin Heavy Chains Lymphatic Diseases Middle Aged
21
(43.8%)
20194090
Multicentric Castleman disease: report of rare disease in Kuwait.
Mohammad BA, Al-Brahim N, Kunjhibava S, Ahmad M, Ahmad M.
Gulf J Oncolog. 2009;(6):48-50.
Anemia Fever Follicular hyperplasia
Homo sapiens Male Middle Aged
21
(43.8%)
1542967
[Angiofollicular lymph node hyperplasia (Castleman disease)].
Pedersen LM, Nielsen H.
Ugeskr Laeger. 1992;154(10):621-4.
Anemia Fever Lymphadenopathy
Differential Diagnosis Homo sapiens Male Middle Aged
24
(40.3%)
17616028
(2687612)
Castleman disease presenting with jaundice: a case with the multicentric hyaline vascular variant.
Park JB, Hwang JH, Kim H, Choe HS, Kim YK, Kim HB, Bang SM.
Korean J Intern Med. 2007;22(2):113-7.
Jaundice Lymphadenopathy Lymphoproliferative disorder
Abdominal Pain Adrenal Cortex Hormones Biopsy Homo sapiens Icterus Male Middle Aged Positron-Emission Tomography Vascular Diseases X-Ray Computed Tomography
25
(39.6%)
31253137
Hyaline vascular variant of unicentric Castleman disease of the tonsil: a case report.
Li P, Liu H, Li H, Li A, Yu G, Yin W.
Diagn Pathol. 2019;14(1):70.
Plethora Follicular hyperplasia Lymphoproliferative disorder
Adult Differential Diagnosis Homo sapiens Hyalin Substance Immunohistochemistry Lymphocyte Lymphoid Tissue Lymphoproliferative Disorders Male Palatine Tonsil
26
(38.8%)
30009125
(6038051)
Successful rituximab treatment of TAFRO syndrome with pathological findings of glomerular endothelial damage.
Noda Y, Saka Y, Kato A, Mimura T, Naruse T.
Clin Nephrol Case Stud. 2018;6:16-20.
Edema Ascites Thrombocytopenia
26
(38.8%)
28367597
Salvage therapy with lenalidomide containing regimen for relapsed/refractory Castleman disease: a report of three cases.
Zhou X, Wei J, Lou Y, Xu G, Yang M, Liu H, Mao L, Tong H, Jin J.
Front Med. 2017;11(2):287-292.
Ascites Pleural effusion Lymphoproliferative disorder
Adult Combined Modality Therapy Homo sapiens Male Middle Aged Remission Induction Salvage Therapy Transplantation, Autologous Young Adult
28
(37.6%)
30235674
(6160051)
Castleman disease mimicking systemic lupus erythematosus: A case report.
Wang L, Chen H, Shi J, Tang H, Li H, Zheng W, Zhang F.
Medicine (Baltimore). 2018;97(38):e12291.
Proteinuria Glomerulonephritis Anemia
DDIT3
Anemia Differential Diagnosis Fever Glomerulonephritis, Membranoproliferative Homo sapiens Lupus Erythematosus, Systemic Male Middle Aged Nephrotic Syndrome Serositis Thrombocytopenia
28
(37.6%)
26387507
Anemia and autoimmunity markers in an adolescent with Castleman disease.
Fretzayas A, Stasinopoulou A, Moustaki M, Stefos E, Kaniouras G, Nicolaidou P.
Pediatr Int. 2015;57(6):1199-201.
Anemia Autoimmunity Low-grade fever
IL6
Anemia Biological Markers Differential Diagnosis Females Homo sapiens Magnetic Resonance Imaging Positron-Emission Tomography X-Ray Computed Tomography
30
(37.6%)
24367988
Iron-refractory microcytic anemia as the presenting feature of unicentric Castleman disease in children.
Chandrakasan S, Bakeer N, Mo JQ, Cost C, Quinn CT.
J Pediatr. 2014;164(4):928-30.
Anemia Lymphadenopathy
Child Females Homo sapiens
        

Phenotype(s) retrieved from Orphanet

    Total: 29

HPO ID Term Frequency
HP:0002716 Lymphadenopathy Very frequent (99-80%)
HP:0001824 Weight loss Frequent (79-30%)
HP:0001903 Anemia Frequent (79-30%)
HP:0002027 Abdominal pain Frequent (79-30%)
HP:0002729 Follicular hyperplasia Frequent (79-30%)
HP:0003565 Elevated erythrocyte sedimentation rate Frequent (79-30%)
HP:0011227 Elevated C-reactive protein level Frequent (79-30%)
HP:0012378 Fatigue Frequent (79-30%)
HP:0025142 Constitutional symptom Frequent (79-30%)
HP:0030783 Increased serum interleukin-6 Frequent (79-30%)
HP:0100721 Mediastinal lymphadenopathy Frequent (79-30%)
HP:0000952 Jaundice Occasional (29-5%)
HP:0002017 Nausea and vomiting Occasional (29-5%)
HP:0003270 Abdominal distention Occasional (29-5%)
HP:0008940 Generalized lymphadenopathy Occasional (29-5%)
HP:0011024 Abnormality of the gastrointestinal tract Occasional (29-5%)
HP:0012735 Cough Occasional (29-5%)
HP:0025066 Decreased mean corpuscular volume Occasional (29-5%)
HP:0030157 Flank pain Occasional (29-5%)
HP:0031500 Abdominal mass Occasional (29-5%)
HP:0000083 Renal insufficiency Very rare (4-1%)
HP:0000790 Hematuria Very rare (4-1%)
HP:0001723 Restrictive cardiomyopathy Very rare (4-1%)
HP:0001873 Thrombocytopenia Very rare (4-1%)
HP:0002094 Dyspnea Very rare (4-1%)
HP:0005214 Intestinal obstruction Very rare (4-1%)
HP:0006000 Ureteral obstruction Very rare (4-1%)
HP:0011974 Myelofibrosis Very rare (4-1%)
HP:0012050 Anasarca Very rare (4-1%)


Phenotype(s) retrieved from case reports

    Total: 63

HPO ID Term # of case reports
HP:0005523 Lymphoproliferative disorder 36
HP:0002716 Lymphadenopathy 8
HP:0001271 Polyneuropathy 7
HP:0030731 Carcinoma 7
HP:0002664 Neoplasm 5
HP:0001945 Fever 4
HP:0002721 Immunodeficiency 4
HP:0030150 Plasmacytosis 4
HP:0000969 Edema 3
HP:0001744 Splenomegaly 3
HP:0001903 Anemia 3
HP:0031501 Pelvic mass 3
HP:0100242 Sarcoma 3
HP:0001028 Hemangioma 2
HP:0001433 Hepatosplenomegaly 2
HP:0001891 Iron deficiency anemia 2
HP:0002729 Follicular hyperplasia 2
HP:0008940 Generalized lymphadenopathy 2
HP:0011974 Myelofibrosis 2
HP:0031500 Abdominal mass 2
HP:0000100 Nephrotic syndrome 1
HP:0000112 Nephropathy 1
HP:0000135 Hypogonadism 1
HP:0000572 Visual loss 1
HP:0000790 Hematuria 1
HP:0000819 Diabetes mellitus 1
HP:0000821 Hypothyroidism 1
HP:0000846 Adrenal insufficiency 1
HP:0000952 Jaundice 1
HP:0001138 Optic neuropathy 1
HP:0001370 Rheumatoid arthritis 1
HP:0001541 Ascites 1
HP:0001873 Thrombocytopenia 1
HP:0001894 Thrombocytosis 1
HP:0001909 Leukemia 1
HP:0001935 Microcytic anemia 1
HP:0001955 Unexplained fevers 1
HP:0002024 Malabsorption 1
HP:0002027 Abdominal pain 1
HP:0002094 Dyspnea 1
HP:0002617 Dilatation 1
HP:0002668 Paraganglioma 1
HP:0002835 Aspiration 1
HP:0002960 Autoimmunity 1
HP:0003072 Hypercalcemia 1
HP:0003073 Hypoalbuminemia 1
HP:0003418 Back pain 1
HP:0005200 Retroperitoneal fibrosis 1
HP:0005521 Disseminated intravascular coagulation 1
HP:0009830 Peripheral neuropathy 1
HP:0010280 Stomatitis 1
HP:0011134 Low-grade fever 1
HP:0011506 Choroidal neovascularization 1
HP:0011510 Drusen 1
HP:0011946 Bronchiolitis obliterans 1
HP:0012050 Anasarca 1
HP:0012432 Chronic fatigue 1
HP:0012593 Nephrotic range proteinuria 1
HP:0025289 Cervical lymphadenopathy 1
HP:0032046 Focal cortical dysplasia 1
HP:0100008 Schwannoma 1
HP:0100632 Pulmonary sequestration 1
HP:0100726 Kaposi's sarcoma 1


Causative gene(s) retrieved from Orphanet

    Total: 0

Gene Symbol Gene Name Entrez Gene ID